Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABROCITINIB vs ACECLOFENAC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABROCITINIB vs ACECLOFENAC: Safety Overview

Metric ABROCITINIB ACECLOFENAC
Total FAERS Reports 3,170 500
Deaths Reported 57 281
Death Rate 1.8% 56.2%
Hospitalizations 329 119
Average Patient Age 48.5 yrs 54.5 yrs
% Female Patients 53.9% 57.6%
FDA Approval Date Jan 14, 2022 N/A
Manufacturer U.S. Pharmaceuticals N/A
Route ORAL N/A
Marketing Status Prescription N/A